Precision Science LLC
Translational Data Science & Biomarker Strategy for Precision Medicine
Precision Science LLC
Translational Data Science & Biomarker Strategy for Precision Medicine
Helping biotechnology and diagnostics companies translate complex clinical, biomarker, and multi-omics data into decision-ready insights for clinical development, patient stratification, and regulatory-grade evidence generation.
Precision Science LLC provides expert consulting in translational data science, biomarker strategy, and AI-enabled clinical analytics for biotechnology and diagnostics companies.
Founded by Dr. Chun Zhang, an experienced computational biology and biostatistics leader, the firm helps organizations design and implement data-driven strategies that accelerate precision medicine programs.
Services include biomarker discovery and validation, multimodal data integration across genomic and clinical datasets, statistical and machine learning modeling, and development of regulatory-grade analytical frameworks for clinical trials.
Precision Science works with both emerging biotech companies and established organizations to translate complex biomedical data into actionable insights that inform clinical development and patient stratification.
Biomarker discovery and validation strategy
Translational data analysis planning
Patient stratification and clinical decision support
Predictive and prognostic modeling
Multimodal data integration
High-dimensional data interpretation
Protocol and SAP review
Biomarker-driven analytical framework design
Regulatory evidence generation
Senior-level translational analytics advisory
Fractional data science leadership for emerging biotech and diagnostics teams
Advised biotechnology teams on biomarker discovery, validation, and patient stratification strategies to support translational and clinical development programs.
Developed analytical frameworks integrating clinical, genomic, molecular, and imaging data to identify predictive and prognostic signatures for precision medicine applications.
Applied statistical and machine learning approaches to high-dimensional clinical and biomarker datasets to support outcome prediction, patient segmentation, and decision-ready insights.
Provided expert review of protocol and statistical analysis plans to strengthen analytical rigor, biomarker integration, and clinical decision-making frameworks.
Supported biotech and diagnostics organizations in defining translational analytics strategies, organizational capabilities, and data science roadmaps aligned with program goals.
We welcome inquiries from biotechnology and diagnostics organizations seeking support in translational data science, biomarker strategy, and AI-enabled clinical analytics. If interested, please email: info@precisionsciencebio.com or fill out this form.